Contract W81K0225PA067
Cerus Corporation · Department Of Defense · September 23, 2025
Cerus Corporation was awarded a federal contract by Department Of Defense (Department Of The Army) on September 23, 2025 for $72,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Concord, CA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 30, 2025. If all options are exercised, the contract could reach $367,000.
Contract details
- PIID
- W81K0225PA067
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Concord, CA
- First action
- September 23, 2025
- Latest action
- December 30, 2025
Description
CERUS INTERCEPT PLATELET PROCESSING SETS
Modification timeline
-
December 30, 2025Mod P00002$71.6K
-
December 30, 2025Mod P00001$0
-
September 23, 2025Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0225PA067?
Contract W81K0225PA067 is a federal contract awarded to Cerus Corporation by Department Of Defense on September 23, 2025 for $72,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract W81K0225PA067?
Cerus Corporation won contract W81K0225PA067 from Department Of Defense.
How much is contract W81K0225PA067 worth?
Contract W81K0225PA067 has obligated $72,000 to date, with a total potential value of $367,000 if all options are exercised.